It is conceivable that the extent and the spatio-temperal expression of dozens or even a few hundred genes is significantly altered during the development and progression of atherosclerosis as compared to normal circumstances. It is believed that differential gene In that respect, it is speculated that a member of the Sp/XKLF family, the shear stress-regulated lung Kriippel-like factor (LKLF) may be instrumental for the communication between endothelial cells and smooth muscle cells. Taken together, the expectation can be advanced that the fundamental knowledge obtained on atherogenesis and the data that will be acquired during the coming decade with the new, powerful high through-put methodologies, will lead to novel modalities to treat patients suffering from cardiovascular disease. In view of the phenotypic changes of vascular and blood-borne cells during atherogenesis, one mav speculate that therapeutic interventions should focus on reversal of an acquired phenotype either by a gene therapeutic approach or by the application of specific drugs that interfere with aberrant gene expression.
Introduction
Atherosclerosis is a complex, chronic inflammatory disease of the arterial vessel wall that is manifested at predilected locations of the vasculature (reviewed in: 1-3). Accordingly the current opinion is that this disease is caused by both local and systemic risk factors. Local risk factors are determined by the geometry of the vessels and the view has emerged that bifurcations, branch points and curvatures intrinsically cause irregularities of the otherwise uniform laminar shear-stress (4) (5) (6) . Areas of turbulent flow, resulting in abrupt transitions of low and high shear stress, are particularly prone to develop atherosclerotic lesions. The formation of atherosclerotic lesions is considered as the basis for the etiology of most pathological, cardiovascular events such as coronary heart disease (CHD) (7, 8) . The systemic risk factors, that cause these diseases, have been thoroughly defined by epidemiological studies and traditionally include high plasma cholesterol, smoking, male sex, advanced age, diabetes mellitus, overweight and high blood pressure (9) . Novel risk factors have now been introduced and are under investigation such as hyperhomocysteinemia, impaired fibrinolysis, lipoprotein (a), small dense low-density lipoprotein (LDL) and inflammatory markers (10) . Ever since the epidemiological studies introduced the risk factors for CUD, scientists have been challenged to translate these risk factors into patho-biological pathways and define a molecular basis.
Among the patho-biological processes involved in atherosclerosis, the importance of lipoprotein metabolism in initiation and progression of atherosclerosis has been established by human as well as animal studies. The earliest form of atherosclerosis, called 'fatty streaks', could start as early as in infancy and these lesions contain inflammatory cells, like macrophages and lymphocytes, in addition to accumulated lipids. This has led to the generally accepted hypothesis that atherosclerosis is a chronic inflammatory disease of the vessel wall (reviewed in: 1-3). According to this hypothesis, endothelial cell dysfunction upon different 'injuries', such as oxidized low-density lipoprotein (ox-LDL), is the first step in atherogenesis. The dysfunction leads to increased permeability' and to augmentation of adhesion of leukocytes and platelets to the endothelium. The interaction between endothelial cells and leukocytes or platelets is mediated by selectins, surface-exposed receptors, that bind to defined ligands on the indicated blood cells (11) . Subsequently, leukocytes (e.g. monocytes and T cells) transmigrate through the endothelium by transiently disrupting the gap junctions and the tight junctions between adjacent endothelial cells (reviewed in: 12). In the sub-endothelial space, monocytes differentiate into macrophages and get engaged in digesting large amounts of (modified) lipoprotein particles. Consequently, these cells turn into lipid-laden macrophages ('foam-cells'). The monocytes/macrophages release cytokines and chemokines 1 l hapter1 that will reach the medial smooth muscle cells and strongly affect their fate. Under normal conditions, smooth muscle cells are specialized to provide elasticity and contractabilitv to the arterial vessel wall. However, due to the monocyte/macrophage-derived factors, smooth muscle cells leave their medial location, traverse the internal elastic lamina and migrate into the intima.
Subsequently or simultaneously, smooth muscle cells change from a contractile (differentiated) phenotype into a non-contractile, proliferative (partially dedifferentiated) phcnotvpe, reminiscent of transitions observed during early fetal development (13) (14) (15) . In addition, dedifferentiated smooth muscle cells synthesize vast amounts of extracellular matrix proteins, ultimately resulting in a fibrous lesion that may partially obstruct the circulation. The susceptibility of the lesion with respect to rupture is dependent on the lipid content of the plaque or, more precisely, on the relative amount of fibrous material versus atheromatous core.
Each of the distinct steps in atherogenesis is driven by a set of genes that is expressed by a variety of cells as outlined above. Although, it has been announced that the nucleotide sequence of the entire human genome has now been resolved, it is obvious that only a fraction of the genes and gene products has been characterized. It is conceivable that among the tremendous number of unidentified genes, a subset will be responsible for atherogenesis.
Hence, we are faced with the challenge to identify these genes and elucidate their function, in order to get a firm understanding of the molecular basis of this multifactorial disease.
Fortunately, during the past decade novel high through-put technologies have been developed that provide unbiased approaches to make an inventory of differentially expressed genes.
These technologies have been recently applied in cardiovascular research by our laboratory and by others and will be briefly outlined in the next paragraph.
There is no doubt that genes expressed in the liver and the intestine have an important role in lipid metabolism and in atherogenesis. However, this review focuses on genes expressed by the vascular cells and, consequently, we will refrain from discussing genes expressed in the aforementioned organs. We have chosen to separately elaborate on the contribution of endothelial cells, smooth muscle cells and monocytes/macrophages to atherogenesis. It is expected that in the near future integration of the results with separate cell types will be done e.g. by employing co-culture systems of vascular cells as has been described previously (16, 17) . Furthermore, in view of the molecular complexity of the patho-physiology of atherogenesis, we have restricted this review to a discussion of recent data on the contribution of specific (families of) transcription factors which regulate genes that are possibly causative determinants for initiation and progression of atherosclerosis. In particular, recent data on the role of nuclear factor-KB (NF-KB), peroxisome proliferation-activating receptors (PPARs) and the Sp/XKLF family of zinc finger proteins will be discussed. Finally, arguments can 12 bc advanced to support the notion that interfering with the action of these transcription factors, or with up-stream or down-stream events related to these factors, may provide opportunities to develop new diagnostic tools and therapeutic agents and modalities to prevent the formation of lesions or to induce their regression.
High through-put techniques to monitor differential gene expression
Three major techniques have been developed during the last decade that allows high throughput analysis of differential gene expression in complex organisms. These techniques are denoted differential display of randomly-primed mRNA by RT-PCR pD/RT-PCR) (18, 19) , serial analysis of gene expression (SAGE) (20) and DNA micro-arrav (21) . Our laboratorv has implemented and validated each of these techniques and we believe that each of them has its specific merits and drawbacks. (19) . SAGE does provide quantitative data on the level of (differential) mRNA synthesis, but obtaining a collection of statistically relevant data depends on the availability of large-scale DNA sequencing facilities. Since both techniques rely on amplification of mRNA by RT-PCR, they are both very sensitive. DNA micro-array is based on hybridization of radio-labeled or fluoresccntly labeled cDNA preparations to either filter-or glass-immobilized single-stranded cDNA or a series of gene-specific and control oligonucleotides. The amplified, labeled cDNA preparation should be a qualitative and quantitative representation of the mRNA profile of a given tissue, cell type or mixture of different cells and, hence, is highly heterogeneous in terms of amount of distinct mRNAs. As a consequence, the sensitivity of hybridization, which is determined among others by the concentration of the hybridizing counterpart (probe), might be modest for genes that arc expressed at a very low mRNA level. On the other hand, DNA micro-array is a genuine high through-put technique that in principle allows a 'genome-wide' comparison of for example gene expression of a chosen cell type/tissue under different conditions or of two different cell types under the same condition. As an illustration of large-scale gene expression profiling, tumor endothelium has been compared with normal endothelium, using SAGE (22) . Undoubtedly, similar studies 13 will be undertaken to compare the transcriptome of vascular cells under atherosclerotic circumstances and that of their healthy counterparts.
We have recently designed and applied a combined protocol of DD/RT-PCR and DNA micro-array. Initially, DD/RT-PCR had been employed to isolate and identify genes differentially expressed in cultured human vascular endothelial cells and smooth muscle cells that were subjected to a strong atherosclerotic stimulus (23, 24) . In addition, we also performed an extensive SAGE to delineate genes that are specifically induced or repressed upon activation of cultured human smooth muscle cells (25) . Together with cDNAs, corresponding to genes differentially expressed upon the transition of cultured human monocytes into macrophages (Y. Sier-Ferreira, B.M.M. van den Berg, H. Pannekock, unpublished data), we composed a limited, 'custom' human vascular DNA micro-array that contains about 350 cDNAs (26) . These arrays are currendv used to analyze expression of this pre-selected set of genes in specimens collected during major vascular surgery or in vascular material that has been obtained from organ donors (27) . Obviously, the bioinformatics required to 'read' these custom arrays is relatively straightforward as compared to genome-wide screens that will be available in due time.
Vascular cells
The non-atherosclerotic ('healthy') vessel wall contains only two different cell types, endothelial cells and smooth muscle cells, each of which has a well-defined role. Under these conditions, the monocellular endothelial layer forms a barrier that permits transport of nutrients to the sub-endothelial space. The endothelial cells synthesize products that are important to maintain the contractile function of the underlying smooth muscle cells. This communicative function is attributed in particular to small molecules like prostanoids, endothelins and nitric oxide (NO). Indications are at hand, however, suggesting that additional pathways are also involved in the communication between endothelial cells and smooth muscle cells. I lence, it is foreseen that future studies will focus on the identification of these molecules and the elucidation of their function. In this respect, the seminal studies on the interplay between cardiac microvascular endothelial cells and cardiomyocytes may serve as an illuminating example (28) (29) (30) (31) . In that case, it was demonstrated that differential 
Endothelial cells
The endothelium covers the luminal side of the entire cardiovascular system and has been considered a distinct organ. It covers approximately 700 m -, weighs 1.5 kg and regulates many processes (32, 33) . It forms a non-thrombogenic, non-adhesive layer and regulates vascular tone. It is now generally accepted that endothelial dysfunction is the first step in atherosclerosis (reviewed in: 1-3). Endothelial dysfunction refers to impaired biological processes in endothelial cells, leading to increased adhesiveness to monocytes, increased permeability, procoagulant properties and changes in vascular tone. However, in clinical settings endothelial dysfunction has been used to describe the impaired nitric oxide (NO) derived vasodilatation. Endothelial cells are exposed to a variety of biochemical and biomechanical stimuli, such as circulating LDL, inflammatory cytokines, fluid shear stress and cyclic stretch (4) (5) (6) 34) . Since it is generally assumed that atherosclerosis is due to an interplay between genes and environmental factors, different individuals should react is Chapter 1 differently to these stimuli. Accordingly, experiments with mice of a different genetic background illustrate a different sensitivity towards atherogenic stimuli and differences in the gene expression pattern of their endothelial cells (35) . Bv using two strains of mice, one resistant (C3H/HeJ) and the other susceptible (C5~BL/6J) to diet-induced atherosclerosis, it was shown that cultured endothelial cells isolated from these strains of mice reacted differently to stimuli. Ahnimallv-modified LDL induced higher levels of inflammatory genes in cultured endothelial cells derived from the C57BL/6J mice than in those derived from C311/1 lej mice. This study not only explains, at least pardy, the differences in susceptibility of these mice, but also illustrates that factors acting in the vessel wall could protect against diet-induced atherosclerosis. Finally, these observations imply that altering the expression profile of vascular cells, by for instance gene therapy or local drug delivery, might be a useful modality-to treat atherosclerosis.
Since atherosclerosis is considered a chronic inflammatory disease of the vessel wall, it is obvious that special attention should be given to the transcription factor, nuclear factor KB Finally, it should be noted from the catalogue of differentially expressed genes ( Table 1) that activation of endothelial cells with a 'strong' atherosclerotic stimulus, i.e. TXF-a or
TNF-a-containing conditioned medium of ox-LDL-treated monocytes, results in alterations
of an impressive number of diverse processes such as haemostasis, leukocyte trafficking, regulation of transcription, protection against oxidation, cell shape and cell cycle, signal transduction and apoptosis.
Despite the importance of systemic factors for initiation and progression, atherosclerosis develops at prcdilected sites in the arterial tree, such as the outer edges of vessel bifurcations, branch points and curvatures (4) (5) (6) 34) . In these susceptible areas, laminar blood flow is disturbed resulting in a low shear stress. It has been postulated that the gene expression pattern of the endothelial cells is modulated at the transition of high to low shear stress, leading to a focal atherogenic phenotype of these cells (40) (41) (42) . Indeed, in vitro studies have
shown that the mRNA profile of cultured endothelial cells changes upon applying shear stress. For instance, endothelial NO-synthase (eNOS), an enzyme that catalyses the production of the vasodilator NO, is increased in vitro by fluid shear stress (43) . En-face examination of endothelial-cell surfaces in human thoracic aortas revealed a pro-athcrogenic phenotype in areas with low shear stress (accumulation of sub-endothelial macrophages and lymphocytes, irregular endothelial morphology with denuded regions) (44) . Recently, evidence has been acquired that the effects of low shear stress are also transmitted through the NF-KB pathway (45) . These investigators showed that areas with disturbed flow (high r Chapter 1 probability) in mice aorta display a higher expression level of NF-KB as compared to areas with high shear stress (low probability region). Upon feeding an atherogenic diet to these mice, NF-KB was predominandy activated in those high probability areas, leading to the conclusion that these areas are primed for activation bv various stimuli, whereas the low probability regions with high shear stress are apparently resistant to diet-induced atherosclerosis. These studies show that high shear stress indeed induces a quiescent, antiatherogenic phenotype of the endothelial cells and it is speculated that this is accomplished by interfering with inflammatory pathways. In agreement with the previous sections, here we will focus on differential expression of transcription factors in smooth muscle cells. Interestingly, we found that the central transcription factor NF-KB is up-regulated in activated cultured smooth muscle cells and encountered in the DD/RT-PCR analysis. As mentioned before, this observation with cultured smooth muscle cells coincides with a study showing that activated NL-KB is present in human atheromas, but not in apparently healthy arteries (36) . furthermore, the data are also in agreement with the finding that the products of many genes, that are induced by 19 NF-KB, arc detected in the plaque (49) . NF-KB is also a crucial player in the delicate balance that determines apoptosis or protection against programmed cell death. These processes are of prime importance for the generation and regression of fully developed plaques. The properties of NF-KB to both promote apoptosis and to counteract this process are illustrated by the following findings. Activation of smooth muscle cells by a cocktail of cytokines (containing e.g. TNF-OC) causes synthesis of XF-KB, as revealed by our DD/RT-PCR experiment ( Table 1) . As a consequence of the activation of the NF-KB pathway, downstream genes are induced that are known to inhibit apoptosis, notably inhibitor of apoptosis protein-1 (hIAP-1) and FLICE-likc inhibitory protein (FLIP) (50) (51) (52) (53) (54) .
Next to the induction of NF-KB and its subsequent down-stream genes, it is also of interest Finally, we will mention new data that may serve as an example for the intricate regulation of gene expression that determines the phenotvpe of smooth muscle cells (15) . In addition, it may be instructive to illustrate the potentially crucial role of the Sp/XKLF familv of zinc finger transcription factors in atherogenesis. As stated before, dedifferentiation of quiescent, contractile smooth muscle cells into proliferative cells is characterized by down-regulation of contractile proteins, such as SMct-actin and SM22a (13) . Conversily, maintenance of the quiescent, contractile state is strongly promoted by transforming growth factor (3 (TGF-|3) (1, 2) . This effect of TGl'-(3 is mediated by a specific TGF-P control element (TCE), identified in die promoter of SM a-actin and SM22a (15, 64) . It was shown that members of the Sp/ XKLF family of transcription factors interact with the TCE. Gut-enriched Krüppel-like factor (GKLF) was found to bind to the TCE and to repress TGF-P-promoted transcription of SM22a. Accordingly, expression of GKLF in proliferative smooth muscle cells is high and is specifically down-regulated by TGF-P when the cells become quiescent. In contrast to the repressing effect of GKLF, overexpression of another XKLF family member (BTILB2)
augmented the TGF-[3-depcndent increase in SM220C mRNA synthesis: these findings arc specific for BTEB2 since LKLF did not affect SM22a expression (15) . In conclusion, the often ubiquitously expressed members of the Sp/XKLF family are structurally similar proteins that bind to the same so-called GC/GT boxes in transcription regulatory elements.
Nevertheless, they exhibit a high degree of specificity that is explained by a competitive mechanism in which differences between DXA binding affinity to a given GC/GT box and the relative concentration of the XKLFs would determine the prevalence of a particular family member (46) . In aggregate, these studies together with the discussed effect of endothelial LKLF on the organization of smooth muscle cells during mouse embryogenesis, and possibly also post-natally, emphasize the importance of the Sp/XKLF" family in the maintenance of the integrity of the vessel wall.
A lonocytesl macrophages
The attachment of monocytes to activated endothelial cells, followed by extravasation into the intima, are crucial steps in the development of atherosclerotic lesions. Monocytes differentiate in the vessel wall into macrophages and generate lipid-laden 'foam cells'. To define the molecular mechanisms of gene expression during the process of macrophage differentiation, Hashimoto and colleagues employed SAGE to delineate differential gene expression upon the transition of monocytes into macrophages, induced by granulocyte-
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macrophage colony-stimulating factor (GM-CSF) (65) . In view of our specific referring to the involvement of the Sp/XKLF family of transcription factors in atherogenesis, these investigators detected down-regulation of a family member of the XKLF family, but did not unveil its explicit identity". Remarkably, none of the PPAR family members were identified in this screen. This result is unexpected since it has been shown that treatment of monocytes with ox-LDL causes differentiation into macrophages and induction of PPARy expression (66, 67) . The ultimate influence of PPARy expression and activation on atherosclerosis has been puzzling, although recent observations have shed light on this enigmatic issue (see below). First, it has been shown that PPARg-specific ligands inhibit the expression of inflammatory genes {e.g. TNF-a, interleukin-1P (IL-iP)) (68, 69) . Hence, these results would indicate that PPARy and its specific ligands act as anti-inflammatory and anti-atherogenic agents. Second, it has been demonstrated that activated PPARy up-regulates the synthesis of CD36, a major scavenger receptor on macrophages that mediates uptake of ox-LDL and, consequently, promotes removal of its own inducer {i.e. ox-LDL) (66) . It should be noted, however, that up-regulation of CD36 would be expected to be pro-atherogenic, since CD36 deficiency in mice susceptible to diet-induced atherosclerosis due to apoE deficiency (CD36'' apoE ' ) protects against atherosclerosis (70) . An apparendv contradictory observation is that the PPARy-specific agonists rosiglitazonc and GW'7845 strongly inhibited the development of atherosclerosis in LDL receptor-deficient (LDL-R ) mice (59) . These enigmatic data might be reconciled by yet another effect of activated PPARy. Notably, PPARy ligands promote apoptosis by inhibiting the anti-apoptotic NF-KR signalling pathway (71) .
Possibly, programmed death and subsequent removal of macrophages may restrict the size of the lesion. Finally, recendy three 'back-to-back' papers provided a rationale for the puzzling effect of PPARy activation on atherosclerosis (72) (73) (74) . It was demonstrated that the induction of CD36 by PPARy is actually counteracted by reduced expression of another scavenger receptor (SR-A). In addition, a nuclear receptor of the steroid/thyroid family LXR-ct is upregulated by PPARy and induces the expression of the reverse cholesterol transporter ABCA1.
1 lence, the net result of PPARy activation is anti-atherogenic in foam cells and now provides a rational explanation for the beneficial effects of PPARy specific agonists.
